Groups

Fund universe
View all funds
Groups A-Z
Group name
Fund universe
View funds in this group

News & Research

PIMCO

Fidelity's perfect ISA portfolio using its own best-buy funds

Matteo Anelli
11 March 2026
Fidelity's investment director picks funds for four types of investor.

Why this top multi-asset fund has halved its bond allocation since 2022

Jonathan Jones
10 March 2026
The managers have turned back to alternative assets.

Making hay in the sunshine as biotech’s outlook brightens

Ailsa Craig and Marek Poszepczynski
10 March 2026
After a turbulent 2025, the International Biotechnology Trust managers see improving M&A activity, stronger financing markets and a more pragmatic FDA as reasons for optimism.

Hargreaves Lansdown’s three funds to add to your ISA before the deadline

Jonathan Jones
09 March 2026
The end of the tax year is fast approaching, with just four weeks until the new financial year.

Junior ISA fund and trust picks to pay off a student loan

09 March 2026

Japan’s moment: Why the market no longer needs the world to cooperate

06 March 2026

The right pensions call that looked like the wrong one

06 March 2026

Fundswire

AI Isn’t Coming For Your Job. It’s Coming For Your Mind

Baillie Gifford
10 March 2026
Read more

Rob Lovelace on the year ahead

Capital Group
10 March 2026
Read more

Premier Miton CIO’s Market Watch covering February

Premier Miton
10 March 2026
Read more

Our view on a week in world markets

Liontrust Asset Management
10 March 2026
Read more

How to spot an AI bubble

Capital Group
09 March 2026
Read more

Performance Tables

Contact Details

5th Floor, 76 Sir John Rogerson's Quay, Docklands, Dublin, DO2 C9D0

MN

https://europe.ark-funds.com

info-europe@ark-invest.com

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.